Triple receptor agonist
R3TA
Retatrutide
Read profile
R3TA is shorthand for retatrutide. It acts on the GIP, GLP-1 and glucagon receptors.
Evidence
Investigational. Human clinical trials are studying its effects. It has no approved consumer use.
Lilly · Retatrutide research